Allogeneic Anti-CD19 CAR-T for Refractory Graves' Disease
Clinical trial NCT07129642 · RECRUITING
Trial details
- NCT number
- NCT07129642
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-10
- Primary completion
- 2026-12-31
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.